Lundbeck's operating model for supporting global regulatory activities related to obtaining and maintaining marketing authorizations worldwide has been rated best in the pharmaceutical industry. A new global survey of 70 pharmaceutical companies sees Lundbeck achieve the highest overall score for its global regulatory affairs capabilities. With a score just below the "World Class" threshold, Lundbeck comes first compared to companies like GSK, Pfizer, Lilly, Merck and Novo Nordisk.
Our regulatory work basically ensures Lundbeck medicines to be available in geographies worldwide. To do this efficiently and ensure fast patient access to our high-quality products, the global regulatory systems, processes and organization must run like a well-oiled machine. And we now have word for the fact that no one does it better than Lundbeck.